Covidien Ltd. (NYSE: COV, BSX: COV) will report fourth–quarter results before trading begins on November 17, 2008. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:
- At Covidien´s website: http://investor.covidien.com
- By telephone: For both "listen–only" participants and those participants who wish to take part in the question–and–answer portion of the call, the telephone dial–in number in the U.S. is 866–800–8649. For participants outside the U.S., the dial–in number is 617–614–2703. The access code for all callers is 91716204.
- Through an audio replay: A replay of the conference call will be available beginning at 10:30 a.m. on November 17, 2008, and ending at 11:59 p.m. on November 24, 2008. The dial–in number for U.S. participants is 888–286–8010. For participants outside the U.S., the replay dial–in number is 617–801–6888. The replay access code for all callers is 97956744.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry–leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2007 revenue of nearly $9 billion, Covidien has more than 42,000 employees worldwide in 57 countries, and its products are sold in over 130 countries. Please visit www.covidien.com to learn more about our business.
